ArticleBritish journal of cancer2014

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate.

F Khanim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.